Gibson Dunn

David Lübkemeier

Deals
1
Latest
Feb 2026

Firm

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals David Lübkemeier was named on, most recent first
Feb 2026 AiCuris Anti-infective Cures AG –Veloxis PharmaceuticalsAcquisitionLegal adviser to shareholders (target)Announced913.0Pharma+1Veloxis Pharmaceuticals acquisition of AiCuris Anti-infective Cures AG

Deals where David Lübkemeier is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.